Fujifilm Holdings Corporation, better known as Fujifilm or simply Fuji, stylized as FUJiFILM, is a Japanese multinational photography and imaging company headquartered in Tokyo.

FUJIFILM Diosynth Announced Gene Therapy Services Expansion

FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO) has announced the expansion of its gene therapy services with the additio...

FUJIFILM in Exclusive Licensing Agreement with Cynata

FUJIFILM Corporation announced that it has signed an exclusive licensing agreement with Cynata Therapeutics Limited (Chief Executive Officer: Ross Macdonald), an Australian bio-venture, to obtain worl...

FUJIFILM Irvine Scientific Opens Facility in Netherlands

FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open a third manufacturing facility located in Tilburg, Neth...

Fujifilm to Acquire Biogen Manufacturing Site

FUJIFILM Corporation (“Fujifilm”) today announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød ne...

Fujifilm Partners with Universities to Grow Bioprocessing

Leading contract development and manufacturing organisation (CDMO) Fujifilm Diosynth Biotechnologies has announced a strategic partnership with a number of academic institutions to expand its bioproce...

Fujifilm Presents Advanced Mammalian Expression System

FUJIFILM Diosynth Biotechnologies (Fujifilm), a CDMO with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has introduced its next generation Apollo ...

Fujifilm Invests $90m to Expand its FDB

Fujifilm Corporation announced plans to invest approximately $90 million to expand its bio contract development and manufacturing organization (CDMO) business— Fujifilm Diosynth Biotechnologies (FDB)....

Voyager Therapeutics entered into collaboration with Brammer Bio and Fujifilm

Voyager Therapeutics announced that it has entered into collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to expand manufacturing capabilities.

FUJIFILM Diosynth Biotechnologies receives investment for its bioscience campus

A £7 million (approximately €7,9 million) investment into FUJIFILM Diosynth Biotechnologies facility has been agreed by the local authorities of Tees Valley (UK).

Fujifilm developed new technology to advance the process of drug development

FUJIFILM has developed AI and simulation technology capable of automatically searching and designing new drug candidates from the structural formula of a known biologically active compound.

Fujifilm will start testing of the new stem cell therapy

Fujifilm will apply for permission as soon as this fiscal year to run clinical trials on a treatment using a type of stem cell derived from adult tissue.

Fujifilm buys two leading cell culture media companies

stem cells
FUJIFILM Corporation completed the acquisition of Irvine Scientific Sales Company, Inc. and IS JAPAN CO.,LTD., leading companies in cell culture media for about $800 million.

Fujifilm signed a distribution agreement with R-Pharm

FUJIFILM Corporation signed a distribution agreement with a major Russian pharmaceutical company JSC “R-Pharm” for the distribution of Fujifilm's medical devices in Russia.

Fujifilm set a course towards speeding up development of new drugs

FUJIFILM Holdings conducts its pharmaceutical business focused on the small molecule pharmaceutical products of TOYAMA CHEMICAL and the diagnostic and therapeutic radiopharmaceuticals of FUJIFILM RI Pharma.

Fujifilm buys two leading companies of cell culture media

FUJIFILM Corporation announced that it is acquiring all the outstanding shares of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN (ISJ), leading companies in cell culture media.

Fujifilm will build a new liposome drugs manufacturing facility

FUJIFILM Corporation will invest approximately $37 million in the pharmaceutical production site of its group company, Toyama Chemical Co., Ltd., to build a new manufacturing facility in Toyama prefecture, Japan.